Cell & Gene - Meeting on the Med

In April 2026, Rome will host a new edition of Cell & Gene On The Med, an international event dedicated to cell and gene therapies and Advanced Therapy Medicinal Products (ATMPs).

Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 55+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

This meeting will bring together more than 400 participants from over 20 countries, including biotechs, pharmas, CDMOs, academic centres, hospitals, investors and regulatory experts. Over two days, the programme will combine strategic conferences (30+ international speakers), sector-specific round tables and a partnering platform with more than 300 B2B meetings expected.

For BioWin members active in the fields of innovative therapies, advanced manufacturing, clinical trials, regulatory services or investment, this event is a unique opportunity to:

• Identify new scientific and industrial partners
• Develop European and Mediterranean collaborations
• Access investors specialising in Cell & Gene
• Position themselves in a rapidly growing value chain
• Participation in Cell & Gene On The Med is fully in line with the international development and structuring of the Cell & Gene sector in Europe.